Previous Close | 1.9900 |
Open | 2.0050 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 1.9490 - 2.0290 |
52 Week Range | 1.8510 - 7.3000 |
Volume | |
Avg. Volume | 20,360 |
Market Cap | 2.664M |
Beta (5Y Monthly) | 0.61 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
DALLAS, April 25, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2024 after market close on May 9, 2024.
DALLAS, March 28, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2023.
DALLAS, March 14, 2024--Arcadia Biosciences Inc. (RKDA) will announce its fourth quarter and full year 2023 financial results on March 28, 2024 at 4:30PM ET.